Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux 1.5 mg prophylaxis after major orthopedic surgery in patients with renal impairment
2007-001048-32Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Mar 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fondaparinux in venous thromboembolism (VTE), sponsored by CHU Saint-Etienne. Started Mar 2007; status: completed.
02
Drugs
fondaparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2007-001048-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001048-32.